HSD120 Tafamidis in the Treatment of Transthyretin Amyloid Cardiomyopathy in Poland: Epidemiological Data and Demographic Data from an Expanded Access Program
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1671
https://www.valueinhealthjournal.com/article/S1098-3015(23)04801-5/fulltext
Section Title :
Section Order :
11118
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04801-5&doi=10.1016/j.jval.2023.09.1671